Diabetes · Question 34 of 60

Which drug classes have been shown to also protect the heart and vessels in type 2 diabetes with heart disease?

2 answers are correct. Medium Created with AI

Show answer

Answer

  • A GLP-1 receptor agonists
  • B SGLT2 inhibitors

Explanation

Under the 2023 ESC guideline, people with type 2 diabetes and atherosclerotic cardiovascular disease should receive an SGLT2 inhibitor and/or a GLP-1 receptor agonist with proven cardiovascular benefit, regardless of HbA1c. No such protection has been shown for sulfonylureas.

Certifications & exams

Which exam comes next?

You can already practise for 51 exams, and 16 are up for a vote. See all certifications with their official information, cast your vote or suggest your exam.

See all certifications